Percutaneous access versus surgical cut down for TAVR: Where do we go from here?

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Surgery

Background:

• Transcatheter aortic valve replacement (TAVR) is the standard for high-risk severe symptomatic aortic stenosis.
• Percutaneous TAVR without surgical cut-down is gaining traction in the US.
• This approach aims to improve patient recovery and reduce healthcare costs.

Discussion:

• The percutaneous approach is linked to shorter hospital stays.
• It demonstrates similar rates of short- and late-term vascular complications and mortality compared to traditional methods.
• Importantly, it is associated with a significant reduction in disabling stroke and overall hospital costs.

Key Insights:

• Percutaneous TAVR offers comparable clinical outcomes to traditional TAVR.
• Reduced hospital stay and lower costs are significant advantages.
• The technique necessitates advanced endovascular skills for managing potential vascular complications.

Outlook:

• Further adoption of percutaneous TAVR is anticipated.
• Continued research into managing vascular complications will be crucial.
• This approach may become a preferred method for suitable patient populations.